WNC-0901

N/A

Report date: 2024/07/30 10:23:40
NME

Base Information

Drug NameWNC-0901
Drug Alias NameWNC-0901WNC0901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-dependent protein kinase inhibitors
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsMucositisLung NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo ClinicWaynola Biopharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesWaynola Biopharm Inc
Inactive CompaniesN/A
Active IndicationsMucositisLung NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A